Actinium Announces Appointment of Mark Kubik, MBA as Chief Business Officer

Go back to Actinium Announces Appointment of Mark Kubik, MBA as Chief Business Officer
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Delayed: 7.29 +0.03 (0.41%)
Previous Close $7.26    52 Week High $3.50 
Open $7.30    52 Week Low $0.86 
Day High $7.42    P/E N/A 
Day Low $7.19    EPS $-7.61 
Volume 99,396